3,399 Cigna Group $CI Shares Purchased by Mather Group LLC.

Mather Group LLC. increased its holdings in shares of Cigna Group (NYSE:CI) by 57.9% in the third quarter, Holdings Channel reports. The firm owned 9,269 shares of the health services provider’s stock after buying an additional 3,399 shares during the period. Mather Group LLC.’s holdings in Cigna Group were worth $2,520,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of CI. Assetmark Inc. boosted its position in shares of Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after buying an additional 5,963 shares during the period. Mystic Asset Management Inc. acquired a new stake in shares of Cigna Group in the second quarter valued at $2,808,000. KBC Group NV raised its holdings in shares of Cigna Group by 6.4% in the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after buying an additional 22,978 shares during the period. Nykredit A S purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $15,300,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $11,043,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares in the company, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 22,730 shares of company stock worth $6,293,359 over the last 90 days. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of several research reports. Guggenheim increased their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a research report on Friday, July 31st. Wells Fargo & Company raised their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Barclays lifted their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, UBS Group reaffirmed a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.24.

Cigna Group Stock Up 1.2%

NYSE:CI traded up $3.67 during midday trading on Friday, reaching $302.48. The company had a trading volume of 1,545,464 shares, compared to its average volume of 1,692,376. The firm has a market capitalization of $79.93 billion, a price-to-earnings ratio of 12.51, a PEG ratio of 1.01 and a beta of 0.29. The stock’s fifty day simple moving average is $278.87 and its 200-day simple moving average is $281.82. Cigna Group has a 12-month low of $239.51 and a 12-month high of $311.34. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The firm had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period in the previous year, the firm posted $7.20 EPS. Cigna Group’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.50 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is currently 25.82%.

Cigna Group Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.